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Senate Bill 309
• Passed in the Summer of 2018
• Authority to set Drinking Water Maximum Contaminant 
Levels (MCLs) for four specific perfluoroalkyl substances 
(PFAS):
 Perfluorooctanoic acid (PFOA),
 Perfluorooctanesulfonic acid (PFOS), 
 Perfluorononanoic acid (PFNA), & 
 Perfluorohexanesulfonic acid (PFHxS)
• In New Hampshire, the MCLs are the default Ambient 
Groundwater Quality Standard (AGQS).
• Initial proposal of MCLs due January 1st 2019
• SB309 also granted NHDES additional staff.
• A Human Health Risk Assessor and a Toxicologist 
Background on Senate Bill 309
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Goals of the Initial Proposal & Risk 
Assessment as Directed by SB309
1) Review current literature as well as proposed 
regulatory values from other State, Federal, 
International and non-governmental agencies.
1) Derive MCLs protective of human health at all life 
stages and, following adoption, will be reviewed at 
least every 5 years.
2) Conduct a costs & benefits analysis for the proposed 
MCLs for consideration. 
***No required or target cost-benefit ratio***
Background on SB309
Full Report Available at: 
https://www.des.nh.gov/organization/commissioner/pip/
publications/documents/r-wd-19-01.pdf
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5What is the tolerable dose of PFAS, 
or reference dose (RfD)?
 Which animal studies are 
relevant to human health?
 What can the epidemiological 
data tell us?
 What is the best method to 
account for species differences?
Specific PFAS
NH DES Reference 
Dose (RfD)
US EPA Reference 
Dose (RfD)
ATSDR Minimum 
Risk Level (MRL)
PFOA 5.2  ng/kg/d 20  ng/kg/d 3  ng/kg/d
PFOS 8.0  ng/kg/d 20  ng/kg/d 2  ng/kg/d
PFHxS 9.3  ng/kg/d Not assessed 20  ng/kg/d
PFNA 2.5  ng/kg/d Not assessed 3  ng/kg/d
Reference Dose (RfD) Selection
US EPA. 2016. Drinking Water Advisory for Perfluoroctanoic acid (PFOA).
US EPA. 2016. Drinking Water Advisory for Perfluorooctane sulfonic acid (PFOS).
ASTDR. 2018. Toxicological Profile for Perfluoroalkyls Draft for Public Comment. https://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=1117&tid=237
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Animal Serum (ng/ml)
Total Uncertainty
⋅ Dosimetric Adj. Factor (mL/kg/d) = Reference Dose (ng/kg/d)
7What level in drinking water is protective 
for the adverse effect(s)?
 Assume acute effects and infant ingestion 
rates? Or are they chronic and relevant to 
lower ingestion rates?
 What proportion of PFAS exposure is 
attributable to drinking water?
 20% versus 80%? Assuming Infants 
or adults?
 What is the non-drinking water 
background exposure to PFAS?
Relative Source Contribution
Drining Water Dust
Food Others?
Exposure Assumptions
8RfD (ng/kg/d) ⋅ Relative Source Contribution (%)
Water Ingestion Rate (L/kg/d)
= Maximum Contaminant Level (ng/L)
5.2 ng/kgbw/d ⋅ 40 %
0.055 L/kgbw/d
= 38 ng/L
5.2 ng/kgbw/d ⋅ 20 %
0.055 L/kgbw/d
= 19 ng/L
5.2 ng/kgbw/d ⋅ 40 %
0.267 L/kgbw/d
= 7.8 ng/L
Perfluorooctanoic acid (PFOA)
NHDES proposed MCL 
calculation:
Applying the minimum RSC 
(20%) instead of 40%:
Increasing the daily water intake 
rate to that of 1-3 month old 
infants:
Exposure Assumptions
NH Wisdom Portal, Per- and Polyfluoroalkyl Substances (PFAS) Blood Testing and Community Exposure: 
https://wisdom.dhhs.nh.gov/wisdom/#TopicGroup_8203D9F1281247419C5C417B8E591CE7
Estimation of Relative Source Contribution 
by Subtraction Method
Subtraction method applied to all 4 PFAS using blood data 
collected by NH Dept. Health & Human Services from highest 
exposed populations.
Used NH-specific PFAS blood concentrations:
Geometric mean 95th Percentile
PFOA* 4.40 ng/mL 26.6 ng/mL
PFOS** 10.2 ng/mL 31.7 ng/mL
PFHxS** 4.50 ng/mL 26.0 ng/mL
PFNA 0.66 ng/mL 1.70 ng/mL
* PFOA concentrations from exposed population in Merrimack 
(217 participants) & Southern NH (219 participants).
** PFOS & PFHxS concentrations from exposed population in 
Pease, NH (256 participants).
Exposure Assumptions
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95th Percentile
95th Percentile
Estimation of Relative Source Contribution by Subtraction Method
Blood data like this can be used to derive the RSC based on the target 
serum level.
Used the EPA subtraction method:
EPA Reference: US EPA. 2000. Methodology for Deriving Ambient Water Quality Criteria for the Protection of Human Health (2000) Documents. 
Accessed online at: https://www.epa.gov/wqc/methodology-deriving-ambient-water-quality-criteria-protection-human-health-2000-documents
Exposure Assumptions
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Target serum level (ng/mL)− Population background (ng/mL)
Target serum level (ng/mL)
= RSC
43.5 ng/mL− 1.8 (National average) ng/mL
43.5 ng/mL
= 0.96 or 96%Perfluorooctanoic acid (PFOA):
Specific PFAS
Reference Dose 
(RfD ng/kg/d)
Water Ingestion 
Rate (L/kg/d)
Relative Source 
Contribution
PFOA 5.2
0.055
95th percentile lactating 
woman
40%
PFOS 8.0
0.055
95th percentile lactating 
woman
50%
PFHxS 9.3
0.055
95th percentile lactating 
woman
50%
PFNA 2.5
0.055
95th percentile lactating 
woman
50%
Exposure Assumptions
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RfD (ng/kg/d) ⋅ Relative Source Contribution (%)
Water Ingestion Rate (L/kg/d)
= Maximum Contaminant Level (ng/L)
Specific PFAS
NH DES Proposed 
MCLs (ng/L)
EPA Lifetime DW 
Advisory (ng/L)
NJ Proposed MCLs 
(ng/L)
PFOA 38 70 14
PFOS 70* 70 13
PFHxS 85 n/a n/a
PFNA 23 n/a 13 
(passed 2018)
Proposed Maximum Contaminant Levels (MCLs)
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Proposed MCL have not been finalized, and are currently under review 
following significant public comment ending April 2019.
 In the absence of significant federal actions, public engagement has 
been critical to initiating  and guiding the regulatory process.
 NHDES surveillance has found PFAS in a growing number of media 
including groundwater, biosolids and septic systems that eceed
potential standards.
 The toxicokinetics and toxicodynamics of PFAS in humans and animals 
needs to be further characterize to facilitate better risk assessment. 
 Primary and secondary sources of exposure to PFAS are poorly 
understood.
 Additional efforts are required to address the sources and life-cycle of 
PFAS in order to reduce exposure.
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Lessons Learned
 Evaluating methods to accurately estimate benefits at low levels 
(University of New Hampshire collaborators).
 Seeking a scientifically-based grouping (class) approach for risk 
assessment and regulation of these 4 PFAS, and others.
 Consider the use of new modeling approach for breastmilk transfer 
for these and other PFAS (i.e. Goeden et al. 2019 for placental and 
breastmilk transfer).
 In addition to MCLs, NHDES is required to develop a plan for 
Surface Water Standards by January 1st, 2020.
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Next Steps (2019-2020)
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Next Steps (2019-2020)
Image source: https://www.fws.gov/northeast/
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Questions?
Jonathan Ali, Ph.D.
Phone: (603) 271-1359
Email: jonathan.ali@des.nh.gov 
Mary Butow, M.S.
Phone: (603) 271-8693
Email: mary.butow@des.nh.gov 
David Gordon, M.S.
Phone: (603) 271-4608
Email: david.gordon@des.nh.gov 
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Specific PFAS
Animal Study 
Health Effect
Notes & Corresponding Animal Serum 
Concentration
Perfluorooctanoic 
acid (PFOA)
Increased relative 
liver weight
Male mouse study
Duration: 14 days
4,351 ng/mL BMDL10; Loveless et al. 2006, NJDWQI 2017
Perfluorooctane
sulfonic acid (PFOS)
Delayed pup growth 
& development
Reproductive & transgenerational rat study 
Duration: 2 generations
6,260 ng/mL Modeled; Luebker 2005ab, EPA 2016
Perfluorohexane
sulfonic acid (PFHxS)
Reduced litter size
Reproductive & developmental CD-1 mouse study 
Duration: 14 days prior to & through gestation
27,200 ng/mL NOAEL; Chang et al. 2018
Perfluorononanoic 
acid (PFNA)
Increased relative 
liver weight
Reproductive & developmental CD-1 mouse study 
Duration: through gestation, 17 days
4,900 ng/mL BMDL10; Das et al. 2015, NJDWQI 2018
Reference Dose (RfD) Selection
See Reference Slide for full list of references. 18
Animal Serum (ng/ml)
Total Uncertainty
⋅ Dosimetric Adj. Factor (mL/kg/d) = Reference Dose (ng/kg/d)
